PortfoliosLab logo

AgeX Therapeutics, Inc. (AGE)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS00848H1086
CUSIP00848H108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.68
Year Range$0.53 - $1.30
EMA (50)$0.70
EMA (200)$0.81
Average Volume$26.46K
Market Capitalization$25.42M

AGEShare Price Chart


Chart placeholderClick Calculate to get results

AGEPerformance

The chart shows the growth of $10,000 invested in AgeX Therapeutics, Inc. in Nov 2018 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,507 for a total return of roughly -74.93%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%MarchAprilMayJuneJulyAugust
-12.89%
-8.32%
AGE (AgeX Therapeutics, Inc.)
Benchmark (^GSPC)

AGEReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-2.96%8.19%
6M-12.91%-7.42%
YTD-37.68%-13.03%
1Y-49.68%-5.85%
5Y-31.38%11.95%
10Y-31.38%11.95%

AGEMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-26.33%-14.69%24.67%0.82%-15.80%-20.55%22.92%-4.05%
202114.47%15.52%-19.40%-14.81%-7.97%22.05%-12.90%-23.70%-8.74%-13.83%-13.58%55.71%
2020-24.73%-16.06%-19.13%-9.23%33.85%-16.22%11.97%-16.68%-8.29%96.30%11.32%-14.12%
201929.43%9.82%-4.71%12.59%-38.38%30.60%-20.16%-7.17%-27.94%-20.41%-8.97%28.17%
201899.26%-44.63%

AGESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current AgeX Therapeutics, Inc. Sharpe ratio is -0.42. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.42
-0.31
AGE (AgeX Therapeutics, Inc.)
Benchmark (^GSPC)

AGEDividend History


AgeX Therapeutics, Inc. doesn't pay dividends

AGEDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-87.65%
-13.58%
AGE (AgeX Therapeutics, Inc.)
Benchmark (^GSPC)

AGEWorst Drawdowns

The table below shows the maximum drawdowns of the AgeX Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AgeX Therapeutics, Inc. is 90.30%, recorded on Dec 20, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.3%Dec 4, 2018767Dec 20, 2021

AGEVolatility Chart

Current AgeX Therapeutics, Inc. volatility is 39.04%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%MarchAprilMayJuneJulyAugust
39.04%
19.67%
AGE (AgeX Therapeutics, Inc.)
Benchmark (^GSPC)